Literature DB >> 9546974

Exercise in the treatment of claudication: assessment and treatment of functional impairment.

J G Regensteiner1.   

Abstract

Claudication is an important cause of impaired exercise capacity, which limits a patient's ability to walk and thus to meet the personal, social and occupational demands of daily life. Given that improvement of the walking impairment is the primary goal of treating claudication, exercise performance and functional status of patients with claudication should be measured before and after any intervention. Assessment of functional status in both the laboratory and community settings is important so that the various treatments can be judged as to relative efficacy. Studies have shown that exercise training programs have a clinically important impact on functional capacity in persons with claudication. A meta-analysis showed that pain-free walking time increased 180% and maximal walking time increased 120% in claudicants who participated in an exercise program. Substantial improvements have been found in walking speeds and distances (65% and 44%, respectively), caloric expenditure (31%) and physical functioning (67%).

Entities:  

Mesh:

Year:  1997        PMID: 9546974     DOI: 10.1177/1358863X9700200313

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  8 in total

1.  Choosing the individual rehabilitation program for patients with intermittent claudication.

Authors:  A Orsini; G Saggio; G Sinaimeri; L Izzo; F Razionale; S Valabrega; A D'Alessandro; S Mandolesi; P Di Cello; P Izzo
Journal:  G Chir       Date:  2017 Mar-Apr

Review 2.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

3.  Intermittent Claudication.

Authors:  Alan T. Hirsch; Laura M Reich
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06

4.  Medical management and cardiovascular risk reduction in peripheral arterial disease.

Authors:  Ankur Sethi; Rohit R Arora
Journal:  Exp Clin Cardiol       Date:  2008

Review 5.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

Review 6.  Management of lower extremity peripheral arterial disease.

Authors:  Andrew W Gardner; Azhar Afaq
Journal:  J Cardiopulm Rehabil Prev       Date:  2008 Nov-Dec       Impact factor: 2.081

Review 7.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

8.  The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease.

Authors:  Thomas T Tsai; Thomas F Rehring; R Kevin Rogers; Susan M Shetterly; Nicole M Wagner; Rajan Gupta; Omid Jazaeri; Nasim Hedayati; W Schuyler Jones; Manesh R Patel; P Michael Ho; Alan S Go; David J Magid
Journal:  Circulation       Date:  2015-09-11       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.